David Deng
Corporate Officer/Principal bei Verinata Health, Inc.
Aktive Positionen von David Deng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Verinata Health, Inc.
 Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 11.08.2009 | - |
| Direktor/Vorstandsmitglied | 11.08.2009 | 11.08.2009 |
Karriereverlauf von David Deng
Ehemalige bekannte Positionen von David Deng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
Ausbildung von David Deng
| McGill University | Doctorate Degree |
| Shanghai Jiao Tong University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Kanada | 2 |
| China | 2 |
Operativ
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sektoral
| Consumer Services | 3 |
| Health Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Verinata Health, Inc.
Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Health Services |
- Börse
- Insiders
- David Deng
- Erfahrung